Extensive and recalcitrant verrucae vulgares of the great toe treated with imiquimod 5% cream [14]

Journal of the European Academy of Dermatology and Venereology

Volumn 17, Issue 3, 2003, Pages 366-367

  Atzori, Laura ^a   Pinna, A L ^a   Ferreli, C ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ADULT; CASE REPORT; CREAM; CRYOSURGERY; DRUG EFFICACY; DRUG FORMULATION; ELECTROSURGERY; ERYTHEMA; FOLLOW UP; HALLUX; HUMAN; KERATOLYSIS; LABORATORY TEST; LETTER; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECURRENT DISEASE; SKIN COLOR; SKIN DEFECT; SKIN DISEASE; SKIN SCAR; TREATMENT OUTCOME; VERRUCA VULGARIS;

ADMINISTRATION, CUTANEOUS; ADULT; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; DIAGNOSIS, DIFFERENTIAL; FOOT DERMATOSES; HUMANS; MALE; RECURRENCE; TOES; WARTS;

EID: 0038325718     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2003.00792_14.x     Document Type: Letter

References (3)

1. Severson J, Evans TY, Lee P et al. Human papillomavirus infections: epidemiology, pathogenesis, and therapy. J Cutan Med Surg 2001; 5: 43-60.
2. Beutner KR, Spruance SL, Hougham AJ et al. Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol 1998; 39: 741-745.
3. Hengge UR, Esser S, Schultewolter T et al. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 2000; 143: 1026-1031.